[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 2371 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 2371 To require the Secretary of Health and Human Services to conduct a study on the impacts of arsenic, cadmium, mercury, and lead in infant formula on infant health and establish standards for regulating the content of such substances in infant formula. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES July 22, 2025 Mr. Cotton (for himself, Mrs. Britt, Mr. Scott of Florida, and Mr. Hawley) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To require the Secretary of Health and Human Services to conduct a study on the impacts of arsenic, cadmium, mercury, and lead in infant formula on infant health and establish standards for regulating the content of such substances in infant formula. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Safe Baby Formula Act of 2025''. SEC. 2. STUDY ON INFANT FORMULA. Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall complete a study on the impacts of arsenic, cadmium, mercury, and lead in infant formula on infant health. SEC. 3. PROHIBITION OF TOXIC METALS IN INFANT FORMULA. Not later than 90 days after the date of enactment of this Act, the Secretary of Health and Human Services shall-- (1) establish enforcement action levels with respect to arsenic, cadmium, mercury, and lead in infant formula; or (2) establish, through rulemaking, maximum contamination levels for arsenic, cadmium, mercury, and lead in infant formula. SEC. 4. DEFINITION. In this Act, the term ``infant formula'' has the meaning given such term in section 201(z) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(z)). <all>